HomeVIRX • NASDAQ
Follow
Viracta Therapeutics Inc
Previous close
$1.08
Day range
$0.97 - $1.08
Year range
$0.43 - $2.38
Market cap
40.06M USD
Avg Volume
110.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.11%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 13.56M | 17.17% |
Net income | -13.76M | -33.30% |
Net profit margin | — | — |
Earnings per share | -0.35 | -29.63% |
EBITDA | -13.44M | -16.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 53.83M | -41.16% |
Total assets | 56.69M | -40.94% |
Total liabilities | 38.37M | 9.99% |
Total equity | 18.32M | — |
Shares outstanding | 39.27M | — |
Price to book | 3.27 | — |
Return on assets | -55.07% | — |
Return on capital | -68.18% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -13.76M | -33.30% |
Cash from operations | -10.03M | -26.88% |
Cash from investing | 9.27M | 4,666.50% |
Cash from financing | 218.00K | -98.98% |
Net change in cash | -539.00K | -104.05% |
Free cash flow | -5.02M | -24.18% |
About
Founded
1998
Website
Employees
40